pd168393 has been researched along with Ache in 2 studies
PD 168393 : A member of the class of quinazolines carrying bromoanilino and acrylamido substituents at positions 4 and 6 respectively.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Current therapies for cancer-induced bone pain (CIBP) are still limited." | 1.40 | Activation of spinal neuregulin 1-ErbB2 signaling pathway in a rat model of cancer-induced bone pain. ( Jiang, J; Li, K; Wu, X; Yao, P; Zhang, J, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jiang, J | 1 |
| Zhang, J | 1 |
| Yao, P | 1 |
| Wu, X | 1 |
| Li, K | 1 |
| Erschbamer, M | 1 |
| Pernold, K | 1 |
| Olson, L | 1 |
2 other studies available for pd168393 and Ache
| Article | Year |
|---|---|
Activation of spinal neuregulin 1-ErbB2 signaling pathway in a rat model of cancer-induced bone pain.
Topics: Animals; Carcinoma 256, Walker; Cell Line, Tumor; Female; Gene Expression Regulation, Neoplastic; Ne | 2014 |
Inhibiting epidermal growth factor receptor improves structural, locomotor, sensory, and bladder recovery from experimental spinal cord injury.
Topics: Analysis of Variance; Animals; Behavior, Animal; Disease Models, Animal; ErbB Receptors; Female; In | 2007 |